Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Simvastatin in Invasive Bladder Cancer
NCT02360618Phase 2Unknown
- Sponsor
- London Health Sciences Centre
- Start
- Oct 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin, simvastatin in bladder cancer, sponsored by London Health Sciences Centre. Status: unknown.
02
Drugs
metforminsimvastatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02360618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02360618.